Related Experiment Video
Updated: Aug 29, 2025

Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
Post COVID-19 syndrome with impairment of flow-mediated epicardial vasodilation and flow reserve
Amanda Verma1,2, Tarun Ramayya2, Anand Upadhyaya1
1Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Insights
Post-acute sequelae of COVID-19 cardiovascular syndrome (PASC-CVS) may involve impaired epicardial vasodilation. This study found reduced coronary vasodilator capacity in PASC-CVS patients, linked to increased resting blood flow, particularly in women.
Area of Science:
- Cardiovascular Physiology
- Infectious Diseases
- Medical Imaging
Background:
- Post-acute sequelae of COVID-19 cardiovascular syndrome (PASC-CVS) can manifest with various cardiovascular symptoms.
- The underlying mechanisms of PASC-CVS, particularly concerning coronary circulation, require further elucidation.
- Assessing coronary circulatory function is crucial for understanding long-term COVID-19 impacts.
Purpose of the Study:
- To investigate potential alterations in coronary circulatory function in individuals with PASC-CVS.
- To evaluate the association between PASC-CVS and myocardial blood flow (MBF) dynamics.
- To determine if PASC-CVS impacts global myocardial flow reserve (MFR) and epicardial vasodilation.
Main Methods:
- Myocardial blood flow (MBF) and global myocardial flow reserve (MFR) were assessed using 13N-ammonia PET/CT.
- Measurements included resting and hyperemic MBF, and the longitudinal MBF gradient, in PASC-CVS patients and healthy controls.
- Participants were individuals with PASC-CVS without prior cardiovascular risk factors and age-matched healthy controls.
Main Results:
- Patients with PASC-CVS exhibited significantly higher resting MBF compared to healthy controls.
- No significant difference in hyperemic MBF was observed between the PASC-CVS and control groups.
- PASC-CVS patients showed significantly lower MFR and a notable Δ longitudinal MBF gradient, indicating impaired vasodilation.
Conclusions:
- PASC-CVS may be associated with impaired flow-mediated epicardial vasodilation.
- Reductions in coronary vasodilator capacity in PASC-CVS appear primarily linked to elevated resting blood flow.
- Further research is warranted to explore these findings, especially concerning female patients.
Aims:
The aim of this study is to evaluate whether post-acute sequelae of COVID-19 cardiovascular syndrome (PASC-CVS) is associated with alterations in coronary circulatory function.
Materials And Methods:
In individuals with PASC-CVS but without known cardiovascular risk factors (n = 23) and in healthy controls (CON, n = 23), myocardial blood flow (MBF) was assessed with 13 N-ammonia and PET/CT in mL/g/min during regadenoson-stimulated hyperemia, at rest, and the global myocardial flow reserve (MFR) was calculated. MBF was also measured in the mid and mid-distal myocardium of the left ventricle (LV). The Δ longitudinal MBF gradient (hyperemia minus rest) as a reflection of an impairment of flow-mediated epicardial vasodilation, was calculated.
Results:
Resting MBF was significantly higher in PASC-CVS than in CON (1.29 ± 0.27 vs. 1.08 ± 0.20 ml/g/min, p ≤ .024), while hyperemic MBFs did not differ significantly among groups (2.46 ± 0.53 and 2.40 ± 0.34 ml/g/min, p = .621). The MFR was significantly less in PASC-CVS than in CON (1.97 ± 0.54 vs. 2.27 ± 0.43, p ≤ .031). In addition, there was a Δ longitudinal MBF gradient in PASC-CVS, not observed in CON (-0.17 ± 0.18 vs. 0.04 ± 0.11 ml/g/min, p < .0001).
Conclusions:
Post-acute sequelae of COVID-19 cardiovascular syndrome may be associated with an impairment of flow-mediated epicardial vasodilation, while reductions in coronary vasodilator capacity appear predominantly related to increases in resting flow in women deserving further investigations.
Related Concept Videos
Heart Failure II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Mitral Stenosis I: Introduction
Pathophysiology of Heart Failure
Aortic Regurgitation I: Introduction

